Subir Goyal

1.1k total citations
65 papers, 551 citations indexed

About

Subir Goyal is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Subir Goyal has authored 65 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 29 papers in Oncology and 16 papers in Surgery. Recurrent topics in Subir Goyal's work include Prostate Cancer Treatment and Research (12 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Subir Goyal is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Subir Goyal collaborates with scholars based in United States, India and Puerto Rico. Subir Goyal's co-authors include Viraj A. Master, Mehmet Asım Bilen, Ömer Küçük, Bradley Curtis Carthon, Zhengjia Chen, Ashesh B. Jani, Pretesh Patel, Shreyas Joshi, Vishal R. Dhere and Lawrence Boise and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Subir Goyal

54 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Subir Goyal United States	12	236	216	122	107	93	65	551
Pier Paolo Fattori Italy	10	275 1.2×	253 1.2×	97 0.8×	116 1.1×	74 0.8×	24	642
Michael H. Brave United States	9	374 1.6×	158 0.7×	136 1.1×	178 1.7×	71 0.8×	15	664
Akthar Shamsaldin France	11	227 1.0×	216 1.0×	126 1.0×	119 1.1×	62 0.7×	11	768
Daniel Buergy Germany	13	289 1.2×	152 0.7×	157 1.3×	39 0.4×	101 1.1×	29	674
Rebecca S. Tidwell United States	11	351 1.5×	199 0.9×	127 1.0×	111 1.0×	78 0.8×	40	617
Geoffrey Chong Australia	15	393 1.7×	117 0.5×	151 1.2×	95 0.9×	94 1.0×	59	769
Gena Kanas United States	6	407 1.7×	135 0.6×	37 0.3×	79 0.7×	190 2.0×	13	666
Anthea Lau Canada	9	158 0.7×	154 0.7×	57 0.5×	93 0.9×	36 0.4×	28	413
Tanja Pelz Germany	10	157 0.7×	152 0.7×	53 0.4×	44 0.4×	92 1.0×	16	562
Srinivas K. Tantravahi United States	11	173 0.7×	242 1.1×	245 2.0×	199 1.9×	52 0.6×	70	597

Countries citing papers authored by Subir Goyal

Since Specialization

Citations

This map shows the geographic impact of Subir Goyal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subir Goyal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subir Goyal more than expected).

Fields of papers citing papers by Subir Goyal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subir Goyal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subir Goyal. The network helps show where Subir Goyal may publish in the future.

Co-authorship network of co-authors of Subir Goyal

This figure shows the co-authorship network connecting the top 25 collaborators of Subir Goyal. A scholar is included among the top collaborators of Subir Goyal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subir Goyal. Subir Goyal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goyal, Subir, et al.. (2026). Optimal Timing of Adjuvant Therapy in Patients with Poorly Differentiated Pancreatic Adenocarcinoma. Annals of Surgical Oncology.

Jani, Ashesh B., Vishal R. Dhere, Subir Goyal, et al.. (2025). Initial report of a randomized trial of post-prostatectomy prostate cancer radiotherapy using either fluciclovine ( ¹⁸ F) or PSMA ( ⁶⁸ Ga) PET/CT for target dose-escalation.. Journal of Clinical Oncology. 43(5_suppl). 326–326.

Janopaul‐Naylor, James, et al.. (2025). Utilization of Radical Prostatectomy Versus Radiation Therapy for Gleason Grade Group 5 Prostate Cancer Before and After USPSTF Grade D Recommendation Against Prostate‐Specific Antigen Screening in 2012. Cancer Medicine. 14(3). e70624–e70624.

Liu, William, Subir Goyal, Tongrui Liu, et al.. (2024). Antagonizing vasoactive intestinal peptide (VIP) receptors with Muc16CD-directed armored CAR T cells for pancreatic cancer.. Journal of Clinical Oncology. 42(16_suppl). 2558–2558. 1 indexed citations

Liu, Yuan, Subir Goyal, David A. Kooby, et al.. (2024). Differences in preoperative frailty assessment of surgical candidates by sex, age, and race. Surgery Open Science. 19. 172–177. 1 indexed citations

Goyal, Subir, Maria C. Russell, Kenneth Cardona, et al.. (2024). Significance of Specimen Extraction Site in Minimizing Hernia Risk After Distal Pancreatectomy. Annals of Surgical Oncology. 31(13). 8688–8698. 1 indexed citations

Sebastian, Nikhil, Subir Goyal, Yuan Liu, et al.. (2023). Radiation Facility Volume and Survival for Men With Very High-Risk Prostate Cancer Treated with Radiation and Androgen Deprivation Therapy. JAMA Network Open. 6(8). e2327637–e2327637. 2 indexed citations

Yarchoan, Mark, Subir Goyal, Yuan Liu, et al.. (2022). Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer. Clinical Cancer Research. 28(19). 4336–4345. 10 indexed citations

Martini, Dylan J., Subir Goyal, Yuan Liu, et al.. (2022). Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience. SHILAP Revista de lepidopterología. 5(3). 52–57. 1 indexed citations

10.

Dhere, Vishal R., David M. Schuster, Subir Goyal, et al.. (2022). Randomized Trial of Conventional Versus Conventional Plus Fluciclovine (18F) Positron Emission Tomography/Computed Tomography–Guided Postprostatectomy Radiation Therapy for Prostate Cancer: Volumetric and Patient-Reported Analyses of Toxic Effects. International Journal of Radiation Oncology*Biology*Physics. 113(5). 1003–1014. 2 indexed citations

11.

Liu, Yuan, Subir Goyal, Karen D. Godette, et al.. (2021). Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients With Pathologic Negative Nodes After Neoadjuvant Chemotherapy. Clinical Breast Cancer. 22(2). 127–135. 12 indexed citations

12.

Allen, Pamela B., et al.. (2021). Racial differences in clinical presentation and outcomes in mycosis fungoides and Sézary syndrome in the United States: a large singe center retrospective analysis. European Journal of Cancer. 156. S34–S34. 2 indexed citations

13.

Martini, Dylan J., Subir Goyal, Yuan Liu, et al.. (2021). Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade. Frontiers in Oncology. 11. 701345–701345. 7 indexed citations

14.

Martini, Dylan J., Subir Goyal, Yuan Liu, et al.. (2021). Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors. Frontiers in Oncology. 11. 707050–707050. 26 indexed citations

15.

Jani, Ashesh B., Eduard Schreibmann, Subir Goyal, et al.. (2021). 18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial. The Lancet. 397(10288). 1895–1904. 103 indexed citations

16.

Patel, Urvi, Christine Davis, Subir Goyal, et al.. (2021). Safety and Efficacy of 7 Days on/7 Days off Versus 14 Days on/7 Days off Schedules of Capecitabine in Patients with Metastatic Colorectal Cancer: A Retrospective Review. Clinical Colorectal Cancer. 20(2). 153–160. 4 indexed citations

17.

Jani, Ashesh B., Akinyemi A. Akintayo, Oladunni Akin-Akintayo, et al.. (2021). Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on ¹⁸F-Fluciclovine PET/CT Guidance. Journal of Nuclear Medicine. 62(8). 1089–1096. 14 indexed citations

18.

Fischer‐Valuck, Benjamin W., Yuan James Rao, Randall Brenneman, et al.. (2020). Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancer. Brachytherapy. 19(5). 557–566. 2 indexed citations

19.

Schmidt, Timothy M., Benjamin G. Barwick, Nisha S. Joseph, et al.. (2019). Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone. Blood Cancer Journal. 9(12). 94–94. 108 indexed citations

20.

Keller, Deborah S., Michael F. McGee, Subir Goyal, et al.. (2013). Construct validation and comparison of a novel postoperative quality-of-life metric and the Short Form-36 in colorectal surgery patients. Surgery. 154(4). 690–696. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact